Floatz logo

Iron Isomaltoside

Anemia, Iron-Deficiency

China-Japan Friendship HospitalPhase 4 / ApprovedActive
BBB
78/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
67/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Anemia, Iron-Deficiency cohort.

Asset / SponsorPhaseRating
FERRIC CATION
Fundación para la Investigación del Hospital Clínico de Valencia
Phase 4A
IRON(II) SULPHATE (1:1), HEPTAHYDRATE
Linda Malan
Phase 4BBB
SODIUM FERRIC GLUCONATE
Watson Pharmaceuticals
Phase 4BBB
Iron
Cairo University
Phase 4BB
Iron Hydroxide Polymaltose
Kaplan Medical Center
Phase 3BB

View all 13 →

Same molecule, other indications

Iron Isomaltoside is also rated in:

Colorectal SurgeryDormant
BB
Indicative ·
65 / 100
View asset →
colorectal neoplasmDormant
B
Indicative ·
59 / 100
View asset →
colorectal cancerDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →